SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 25 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DLD Asset Management, LP | 10,370,000 | $17,732,700 | 1.93% |
| CSS LLC/IL | 8,157,000 | $13,813,847 | 0.86% |
| Worth Venture Partners, LLC | 917,000 | $1,562,052 | 0.85% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,198,000 | $8,887,187 | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 2,495,000 | $4,354,555 | 0.10% |
| Point72 Asset Management, L.P. | 9,007,000 | $15,327,332 | 0.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,000,000 | $1,696,250 | 0.04% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,082,000 | $8,580,143 | 0.04% |
| SSI INVESTMENT MANAGEMENT LLC | 141,000 | $237,703 | 0.02% |
| LORD, ABBETT & CO. LLC | 3,005,000 | $5,066 | 0.02% |
| D. E. Shaw & Co., Inc. | 7,606,000 | $12,886,582 | 0.01% |
| Leucadia National | 138,000 | $233,879 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5,632,000 | $9,494,651 | 0.00% |
| Nuveen Asset Management, LLC | 2,000,000 | $3,373,720 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| AMERICAN CENTURY COMPANIES INC | 75,000 | $126,625 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,000 | $1,687 | 0.00% |
| CITIGROUP INC | 159,000 | $268,049 | 0.00% |
| MORGAN STANLEY | 152,000 | $256,500 | 0.00% |
| FMR LLC | 1,495,000 | $2,520,331 | 0.00% |
This page lists SAREPTA THERAPEUTICS INC's shareholders in Q2 2023. To view SAREPTA THERAPEUTICS INC's shareholder history, click here.